Show simple item record

dc.contributor.authorWard, Natalie
dc.contributor.authorSahebkar, A.
dc.contributor.authorBanach, M.
dc.contributor.authorWatts, G.
dc.date.accessioned2018-08-08T04:42:43Z
dc.date.available2018-08-08T04:42:43Z
dc.date.created2018-08-08T03:50:54Z
dc.date.issued2017
dc.identifier.citationWard, N. and Sahebkar, A. and Banach, M. and Watts, G. 2017. Recent perspectives on the role of nutraceuticals as cholesterol-lowering agents. Current Opinion in Lipidology. 28 (6): pp. 495-501.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/69896
dc.identifier.doi10.1097/MOL.0000000000000455
dc.description.abstract

Purpose of review Reduction in circulating cholesterol is an important step in lowering cardiovascular risk. Although statins are the most frequently prescribed cholesterol-lowering medication, there remains a significant portion of patients who require alternative treatment options. Nutraceuticals are increasingly popular as cholesterol-lowering agents. Despite the lack of long-term trials evaluating their use on cardiovascular endpoints and mortality, several studies have demonstrated their potential cholesterol-lowering effects. The purpose of this review is to provide an update on the role of nutraceuticals as cholesterol-lowering agents. The present review will focus on individual nutraceutical compounds, which have shown modest cholesterol-lowering abilities, as well as combination nutraceuticals, which may offer potential additive and/or synergistic effects. Recent findings Berberine, red yeast rice, and plant sterols have moderate potential as cholesterol-lowering agents. Combination nutraceuticals, including the proprietary formulation, Armolipid Plus, appear to confer additional benefit on plasma lipid profiles, even when taken with statins and other agents. Summary Although robust, long-term clinical trials to examine the effects of nutraceuticals on clinical outcomes are still required, their cholesterol-lowering ability, together with their reported tolerance and safety, offer a pragmatic option for lowering plasma cholesterol levels.

dc.publisherLippincott Williams & Wilkins
dc.titleRecent perspectives on the role of nutraceuticals as cholesterol-lowering agents
dc.typeJournal Article
dcterms.source.volume28
dcterms.source.number6
dcterms.source.startPage495
dcterms.source.endPage501
dcterms.source.issn0957-9672
dcterms.source.titleCurrent Opinion in Lipidology
curtin.departmentSchool of Public Health
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record